Jane Street Group, LLC Legend Biotech Corp Transaction History

Jane Street Group, LLC

  • $616 Billion
  • Q3 2025

A detailed history of Jane Street Group, LLC transactions in Legend Biotech Corp stock. As of the latest transaction made, Jane Street Group, LLC holds 16,127 shares of LEGN stock, worth $488,486. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,127
Previous 26,660 39.51%
Holding current value
$488,486
Previous $946,000 44.5%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025
SELL
$32.61 - $44.32 $343,481 - $466,822
-10,533 Reduced 39.51%
16,127 $525,000
Q2 2025

Aug 14, 2025
SELL
$27.69 - $37.91 $390,927 - $535,213
-14,118 Reduced 34.62%
26,660 $946,000
Q1 2025

May 14, 2025
SELL
$31.43 - $39.7 $1.48 Million - $1.87 Million
-47,201 Reduced 53.65%
40,778 $1.38 Million
Q4 2024

Feb 14, 2025
BUY
$32.49 - $50.28 $2.54 Million - $3.94 Million
78,318 Added 810.66%
87,979 $2.86 Million
Q3 2024

Nov 14, 2024
SELL
$43.55 - $59.88 $3.17 Million - $4.36 Million
-72,880 Reduced 88.3%
9,661 $470,000
Q2 2024

Aug 14, 2024
BUY
$39.5 - $57.22 $1.7 Million - $2.47 Million
43,143 Added 109.51%
82,541 $3.66 Million
Q1 2024

May 15, 2024
BUY
$55.06 - $69.99 $434,148 - $551,871
7,885 Added 25.02%
39,398 $2.21 Million
Q4 2023

Feb 14, 2024
SELL
$57.25 - $69.74 $62,517 - $76,156
-1,092 Reduced 3.35%
31,513 $1.9 Million
Q3 2023

Nov 14, 2023
SELL
$63.16 - $76.5 $381,044 - $461,524
-6,033 Reduced 15.61%
32,605 $2.19 Million
Q2 2023

Aug 14, 2023
BUY
$46.28 - $75.01 $1.47 Million - $2.39 Million
31,863 Added 470.3%
38,638 $2.67 Million
Q1 2023

May 15, 2023
BUY
$43.42 - $57.37 $294,170 - $388,681
6,775 New
6,775 $326,000
Q3 2022

Nov 14, 2022
BUY
$38.15 - $57.1 $406,640 - $608,628
10,659 Added 65.34%
26,972 $1.1 Million
Q2 2022

Aug 16, 2022
SELL
$33.54 - $55.0 $227,568 - $373,175
-6,785 Reduced 29.37%
16,313 $897,000
Q1 2022

May 17, 2022
SELL
$31.02 - $48.18 $124,824 - $193,876
-4,024 Reduced 14.84%
23,098 $839,000
Q4 2021

Feb 15, 2022
BUY
$41.14 - $56.98 $656,758 - $909,628
15,964 Added 143.07%
27,122 $1.26 Million
Q3 2021

Nov 16, 2021
SELL
$35.31 - $50.56 $601,258 - $860,935
-17,028 Reduced 60.41%
11,158 $564,000
Q2 2021

Aug 16, 2021
SELL
$25.8 - $41.09 $2.61 Million - $4.15 Million
-101,116 Reduced 78.2%
28,186 $1.16 Million
Q1 2021

May 18, 2021
BUY
$23.55 - $32.4 $3.05 Million - $4.19 Million
129,302 New
129,302 $3.75 Million
Q3 2020

Nov 17, 2020
SELL
$27.5 - $39.61 $1.21 Million - $1.75 Million
-44,171 Closed
0 $0
Q2 2020

Aug 17, 2020
BUY
$36.1 - $42.56 $1.59 Million - $1.88 Million
44,171 New
44,171 $1.88 Million

Others Institutions Holding LEGN

# of Institutions
224
Shares Held
57.2M
Call Options Held
231K
Put Options Held
626K
View Full List

About Legend Biotech Corp

LEGN Quotes by TradingView
  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $5.07B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email